المؤلفون: Yongze Zhuang, Hailing Lu, Junxia Li

المصدر: Chronic Diseases and Translational Medicine, Vol 10, Iss 1, Pp 1-11 (2024)

مصطلحات موضوعية: anti‐CD20 monoclonal antibodies, APRIL, biological agents, BLyS, complement, IgA nephropathy, Medicine (General), R5-920

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2589-0514Test

الوصول الحر: https://doaj.org/article/3ccc8c22f38e40bbaaadbdc645c4d0a4Test

المؤلفون: Tali Shafat, Daniel Grupel, Tzvika Porges, Ran Abuhasira, Ana Belkin, Ofir Deri, Yonatan Oster, Shadi Zahran, Ehud Horwitz, Netanel A. Horowitz, Hazim Khatib, Marjorie Vieira Batista, Anita Cassoli Cortez, Tal Brosh‐Nissimov, Yafit Segman, Linor Ishay, Regev Cohen, Alaa Atamna, Amy Spallone, Roy F. Chemaly, Juan Carlos Ramos‐Ramos, Michal Chowers, Evgeny Rogozin, Noga Carmi Oren, Şiran Keske, Orit Wolfovitz Barchad, Lior Nesher, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV)

المصدر: Cancer Medicine, Vol 13, Iss 3, Pp n/a-n/a (2024)

مصطلحات موضوعية: anti‐CD20 monoclonal antibodies, COVID‐19, hematological malignancies, obinutuzumab, rituximab, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2045-7634Test

الوصول الحر: https://doaj.org/article/113128f89fa94947817890d9ed48aae7Test

المؤلفون: Elsa Maitre, Jerome Paillassa, Xavier Troussard

المصدر: Frontiers in Oncology, Vol 12 (2022)

مصطلحات موضوعية: Hairy cell leukemia, HCL, splenic B-cell leukemia/lymphoma with prominent nucleoli, BRAF inhibitors, BTK inhibitors, anti-CD20 monoclonal antibodies, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2022.1068981/fullTest; https://doaj.org/toc/2234-943XTest

الوصول الحر: https://doaj.org/article/bc4f3666b6b243c9a04fee7b4267c618Test

المؤلفون: Kelli M. Money, Ursela Baber, Emma Saart, Soleil Samaan, Jacob A. Sloane

المصدر: Frontiers in Neurology, Vol 13 (2022)

مصطلحات موضوعية: multiple sclerosis, disease modifying therapy, COVID-19 antibody, natalizumab, anti-CD20 monoclonal antibodies, Neurology. Diseases of the nervous system, RC346-429

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fneur.2022.843081/fullTest; https://doaj.org/toc/1664-2295Test

الوصول الحر: https://doaj.org/article/0e39d71420b3452ba6a20ad64049c928Test

المؤلفون: Lal, Anoushka P, Foong, Yi Chao, Sanfilippo, Paul G, Spelman, Tim, Rath, Louise, Levitz, David, Fabis-Pedrini, Marzena, Foschi, Matteo, Habek, Mario, Kalincik, Tomas, Roos, Izanne, Lechner-Scott, Jeannette, John, Nevin, Soysal, Aysun, D'Amico, Emanuele, Gouider, Riadh, Mrabet, Saloua, Gross-Paju, Katrin, Cárdenas-Robledo, Simón, Moghadasi, Abdorreza Naser, Sa, Maria Jose, Gray, Orla, Oh, Jiwon, Reddel, Stephen, Ramanathan, Sudarshini, Al-Harbi, Talal, Altintas, Ayse, Hardy, Todd A, Ozakbas, Serkan, Alroughani, Raed, Kermode, Allan G, Surcinelli, Andrea, Laureys, Guy, Eichau, Sara, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Hodgkinson, Suzanne, Ramo-Tello, Cristina, Maimone, Davide, McCombe, Pamela, Spitaleri, Daniele, Sanchez-Menoyo, Jose Luis, Yetkin, Mehmet Fatih, Baghbanian, Seyed Mohammad, Karabudak, Rana, Al-Asmi, Abdullah, Jakob, Gregor Brecl, Khoury, Samia J, Etemadifar, Masoud, van Pesch, Vincent, Buzzard, Katherine, Taylor, Bruce, Butzkueven, Helmut, Van der Walt, Anneke

المصدر: J Neurol ; ISSN:1432-1459

مصطلحات موضوعية: Anti-CD20 monoclonal antibodies, COVID-19, Cladribine, Disease-modifying therapy, Multiple sclerosis, Natalizumab

العلاقة: https://doi.org/10.1007/s00415-024-12518-7Test; https://pubmed.ncbi.nlm.nih.gov/38935148Test

الإتاحة: https://doi.org/10.1007/s00415-024-12518-7Test
https://pubmed.ncbi.nlm.nih.gov/38935148Test

المؤلفون: Irina N. Bobkova, Elena S. Kamyshova

المصدر: Терапевтический архив, Vol 92, Iss 6, Pp 99-104 (2020)

مصطلحات موضوعية: membranous nephropathy, phospholipase a2 receptor antibodies, anti-cd20 monoclonal antibodies, rituximab, alkylating cytostatics, glucocorticosteroids, calcineurin inhibitors, Medicine

وصف الملف: electronic resource

العلاقة: https://ter-arkhiv.ru/0040-3660/article/viewFile/35009/pdfTest; https://doaj.org/toc/0040-3660Test; https://doaj.org/toc/2309-5342Test

الوصول الحر: https://doaj.org/article/ba08825520ac4f06be44d2db04c65bb2Test

المؤلفون: Daniel M. Klufas, MD, Erin Amerson, MD, Olivia Twu, MD, PhD, Leon Clark, MD, Kanade Shinkai, MD, PhD

المصدر: JAAD Case Reports, Vol 6, Iss 8, Pp 734-736 (2020)

مصطلحات موضوعية: anti-CD20 monoclonal antibodies, ofatumumab, pemphigus vulgaris, rituximab, Dermatology, RL1-803

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2352512620304021Test; https://doaj.org/toc/2352-5126Test

الوصول الحر: https://doaj.org/article/1a15d3e2520f44eb9281ac71578847c3Test

المؤلفون: Akihiro TOMITA, 冨田 章裕

المصدر: 臨床血液 / Rinsho Ketsueki. 2020, 61(8):901

المؤلفون: de Jong, Mathilde R. W., Visser, Lydia, Huls, Gerwin, Diepstra, Arjan, van Vugt, Marcel, Ammatuna, Emanuele, van Rijn, Rozemarijn S., Vellenga, Edo, van den Berg, Anke, Fehrmann, Rudolf S. N., van Meerten, Tom

المصدر: de Jong , M R W , Visser , L , Huls , G , Diepstra , A , van Vugt , M , Ammatuna , E , van Rijn , R S , Vellenga , E , van den Berg , A , Fehrmann , R S N & van Meerten , T 2018 , ' Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach ' , PLoS ONE , vol. 13 , no. 2 , e0193098 . https://doi.org/10.1371/journal.pone.0193098Test

مصطلحات موضوعية: ANTI-CD20 MONOCLONAL-ANTIBODIES, IMPAIR ANTITUMOR-ACTIVITY, NON-HODGKINS-LYMPHOMA, WEE1 KINASE, RITUXIMAB, RECEPTOR, INHIBITORS, CANCER, CHOP, EXPRESSION

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/54bf642b-c5ec-41d1-a45a-133e2e519c3bTest

الإتاحة: https://doi.org/10.1371/journal.pone.0193098Test
https://hdl.handle.net/11370/54bf642b-c5ec-41d1-a45a-133e2e519c3bTest
https://research.rug.nl/en/publications/54bf642b-c5ec-41d1-a45a-133e2e519c3bTest
https://pure.rug.nl/ws/files/54920139/Identification_of_relevant_drugable_targets_in.pdfTest

المؤلفون: Mikulska, Małgorzata, Lanini, Simone, Gudiol, Carlota, Drgona, Lubos, Ippolito, Giuseppe, Fernández-Ruiz, Mario, Salzberger, Bernd

المساهمون: Mikulska, Małgorzata, Lanini, Simone, Gudiol, Carlota, Drgona, Lubo, Ippolito, Giuseppe, Fernández-Ruiz, Mario, Salzberger, Bernd

مصطلحات موضوعية: alemtuzumab, anti-CD20 monoclonal antibodies, blinatumomab, hepatitis B virus, inebilizumab, infection, rituximab

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29447988; info:eu-repo/semantics/altIdentifier/wos/WOS:000454246100007; volume:24 (Suppl. 2); firstpage:S71; lastpage:S82; numberofpages:12; journal:CLINICAL MICROBIOLOGY AND INFECTION; http://hdl.handle.net/11567/893681Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85042918883

الإتاحة: https://doi.org/10.1016/j.cmi.2018.02.003Test
http://hdl.handle.net/11567/893681Test